Sarepta Therapeutics, Inc. SRPT
Set alert
18.81 USD +0.48 +2.65%
As of Nov 3, 10:37 AM ET
18.29 Day range 18.75
14.68 52-week range 24.68
- YTD
- -12.62%
- 1 year
- -23.09%
- Open
- 18.44
- Prev close
- 18.32
- Mkt cap
- 1.98B
- Vol
- 99.55K
- Avg vol
- 2.86M
- EPS
- -1.57
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.29
- High
- 18.75
- Forward P/E
- 7.48
- Beta
- 0.45
- Short ratio
- 7.84
- Inst. own
- 103.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 19.24
- 200-d avg
- 18.72
- 1y target
- 21.64
3M chart
Events in this range
- Aug 5, 2026Earnings: -0.05; estimate 0.2173; surprise -123.01%
- Sep 28, 2026Rating: Needham · Underperform → Underperform
- Sep 30, 2026Rating: JP Morgan · Neutral → Neutral
- Oct 5, 2026Rating: HC Wainwright & Co. · Sell → Sell
- Oct 8, 2026Rating: RBC Capital · Sector Perform → Sector Perform
Signals (16)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 5 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 27, 2026 | 1 week ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| RSI: Overbought | Sep 2, 2026 | 2 months ago |
| RSI: Overbought | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
Held by funds
171 US ETFs and mutual funds hold SRPT · largest positions
Ownership
Held by insiders 4.89%
Held by institutions 103.44%
Float held by institutions 108.75%
Institutions 441
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 17.98% | 18,994,958 | 347.99M | Jun 29, 2026 |
| State Street Corporation | 8.44% | 8,916,090 | 163.34M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 7.93% | 8,377,470 | 153.48M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.35% | 4,591,755 | 84.12M | Jun 29, 2026 |
| Two Sigma Investments, LP | 4.35% | 4,598,735 | 84.25M | Jun 29, 2026 |
| First Trust Advisors LP | 4.13% | 4,365,951 | 79.98M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 6,287,041 | 115.18M | Sep 29, 2026 |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 4.52% | 4,777,645 | 87.53M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.02% | 3,187,072 | 58.39M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.80% | 2,959,707 | 54.22M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.55% | 2,691,583 | 49.31M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.17% | 2,297,038 | 42.08M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARRY RICHARD J | Director | Stock Award(Grant) | Jun 3, 2026 | 3,233,540 |
| BEHRENS M KATHLEEN | Director | Stock Award(Grant) | Jun 3, 2026 | 224,357 |
| CHAMBERS MICHAEL ANDREW | Director | Stock Award(Grant) | Jun 3, 2026 | 504,027 |
| ESTEPAN IAN MICHAEL | Chief Operating Officer | Conversion of Exercise of derivative security | Feb 26, 2026 | 204,699 |
| INGRAM DOUGLAS S | Chief Executive Officer | Stock Award(Grant) | Dec 4, 2025 | 929,391 |
| NICAISE CLAUDE | Director | Stock Award(Grant) | Jun 3, 2026 | 48,407 |